Retatrutide (15mg) Retatrutide is an advanced triple-agonist peptide currently under investigation for its potential to revolutionize metabolic health
Summary: Retatrutide may reduce inflammation indirectly through significant weight loss, but there is currently no confirmed evidence of direct anti-inflammatory effects independent of adiposity reduction
Applicable Procedure Codes: 37243, 75984, 79445, S2095
However, most have recovered after receiving intravenous fluids and anti-nausea medications
[1] [2] It works by enhancing insulin secretion in response to meals, suppressing glucagon release, and slowing gastric emptying
This personalized insight helps your provider optimize your treatment protocol to maximize efficacy while minimizing tolerability challenges from the start